| Year |
Title |
Altmetric |
| 2023
|
Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia.
Clinics in Laboratory Medicine.
43:115-125.
2023
|
|
| 2023
|
Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
Pediatric Blood and Cancer.
2023
|
|
| 2022
|
Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16.
Blood Advances.
6:6131-6134.
2022
|
|
| 2022
|
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Leukemia.
36:1720-1748.
2022
|
|
| 2022
|
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Leukemia.
36:1703-1719.
2022
|
|
| 2022
|
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3 /ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.
Journal of Clinical Oncology.
40:2023-2035.
2022
|
|
| 2022
|
Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group.
Pediatric Blood and Cancer.
69.
2022
|
|
| 2021
|
Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia.
Modern Pathology.
34:2050-2054.
2021
|
|
| 2021
|
Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia.
Clinics in Laboratory Medicine.
41:485-495.
2021
|
|
| 2021
|
Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy
2021
|
|
| 2021
|
Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL)..
Scientific Reports.
11:5154.
2021
|
|
| 2020
|
Acute erythroid leukemia is enriched in NUP98 fusions: A report from the Children's Oncology Group.
Blood Advances.
4:6000-6008.
2020
|
|
| 2020
|
Integrative genomic analysis of B-lymphoblastic lymphoma with intrachromosomal amplification of chromosome 21.
Pediatric Blood and Cancer.
67.
2020
|
|
| 2019
|
Clofarabine can replace anthracyclines and etoposide in remission induction therapy for childhood acute myeloid leukemia: The AML08 multicenter, randomized phase III trial.
Journal of Clinical Oncology.
37:2072-2081.
2019
|
|
| 2019
|
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
Pediatric Blood and Cancer.
66.
2019
|
|
| 2019
|
Genomic subtyping and therapeutic targeting of acute erythroleukemia.
Nature Genetics.
51:694-704.
2019
|
|
| 2019
|
Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma.
Blood.
133:1313-1324.
2019
|
|
| 2019
|
Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude Total Therapy Study 16.
Journal of Clinical Oncology.
37:3377-3391.
2019
|
|
| 2019
|
Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions.
Pediatric Blood and Cancer.
66.
2019
|
|
| 2019
|
Significance of CNS 2 cerebrospinal fluid status post-induction in pediatric and adolescent patients with acute lymphoblastic leukemia.
Pediatric Blood and Cancer.
66.
2019
|
|
| 2019
|
Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor.
OncoImmunology.
8.
2019
|
|
| 2018
|
Mixed-phenotype acute leukemia, T/megakaryoblastic.
Blood.
132:2418.
2018
|
|
| 2018
|
The comparative sensitivity of immunohistochemical markers of megakaryocytic differentiation in acute megakaryoblastic leukemia.
American Journal of Clinical Pathology.
150:461-467.
2018
|
|
| 2018
|
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.
Blood.
132:264-276.
2018
|
|
| 2018
|
NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy
2018
|
|
| 2018
|
Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion.
Transplant Infectious Disease.
20.
2018
|
|
| 2018
|
The genetic basis and cell of origin of mixed phenotype acute leukaemia.
Nature.
562:373-406.
2018
|
|
| 2017
|
CD30 expression in pediatric neoplasms, study of 585 cases
2017
|
|
| 2017
|
BCL-W has a fundamental role in B cell survival and lymphomagenesis.
Journal of Clinical Investigation.
127:635-650.
2017
|
|
| 2017
|
γδ T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Discussion of Two Pediatric Cases and Its Distinction from Other Mature γδ T-Cell Malignancies..
Case Reports in Hematology.
2017:5873015.
2017
|
|
| 2016
|
Prognostic significance of major histocompatibility complex class II expression in pediatric adrenocortical tumors: A St. Jude and children's oncology group study.
Clinical Cancer Research.
22:6247-6255.
2016
|
|
| 2016
|
Phase I study of selinexor, a selective inhibitor of nuclear export, in combination with fludarabine and cytarabine, in pediatric relapsed or refractory acute leukemia.
Journal of Clinical Oncology.
34:4094-4101.
2016
|
|
| 2016
|
Adult T-cell leukemia/lymphoma..
Revista da Associação Médica Brasileira.
62:691-700.
2016
|
|
| 2016
|
Metachronous T-Lymphoblastic Lymphoma and Burkitt Lymphoma in a Child With Constitutional Mismatch Repair Deficiency Syndrome.
Pediatric Blood and Cancer.
63:1454-1456.
2016
|
|
| 2016
|
LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors.
Journal of Clinical Investigation.
126:1267-1281.
2016
|
|
| 2016
|
Diverse and targetable kinase alterations drive histiocytic neoplasms.
Cancer Discovery.
6:154-165.
2016
|
|
| 2015
|
Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels.
Blood.
126:2896-2899.
2015
|
|
| 2015
|
Atypical cutaneous γδ T cell proliferation with morphologic features of lymphoma but with clinical features and course of PLEVA or lymphomatoid papulosis.
Journal of Cutaneous Pathology.
42:1012-1017.
2015
|
|
| 2015
|
The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma.
British Journal of Haematology.
168:845-853.
2015
|
|
| 2015
|
Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy.
British Journal of Haematology.
168:94-101.
2015
|
|
| 2014
|
Loss of PIKfyve in platelets causes a lysosomal disease leading to inflammation and thrombosis in mice.
Nature Communications.
5.
2014
|
|
| 2014
|
Trisomy 21-associated transient abnormal myelopoiesis involving the maternal space of the placenta: A case report and literature review
2014
|
|
| 2014
|
Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site..
Journal of the American Academy of Dermatology.
70:1002-1009.
2014
|
|
| 2014
|
Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.
Cancer.
120:1514-1519.
2014
|
|
| 2014
|
Relapsed nodular sclerosis hodgkin lymphoma and therapy-related myeloid sarcoma in a mediastinal mass.
Blood.
123:1291.
2014
|
|
| 2014
|
Adult T-cell leukemia/lymphoma.
Archives of Pathology and Laboratory Medicine.
138:282-286.
2014
|
|
| 2014
|
Histologic findings in skin biopsy in a JMML rash: A case report and review of literature
2014
|
|
| 2014
|
Phase I Study of the Safety and Pharmacokinetics of Plerixafor in Children Undergoing a Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Leukemia.
Biology of Blood and Marrow Transplantation.
20:1224-1228.
2014
|
|
| 2013
|
RhoA Is Essential for Maintaining Normal Megakaryocyte Ploidy and Platelet Generation.
PLoS One.
8.
2013
|
|
| 2013
|
Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia.
Blood.
121:4925-4929.
2013
|
|
| 2013
|
Intestinal γδ T-cell lymphomas are most frequently of type II enteropathy-associated T-cell type.
Human Pathology.
44:1131-1145.
2013
|
|
| 2013
|
Pediatric MLBL: Challenges remain.
Blood.
121:245-246.
2013
|
|
| 2013
|
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: A report from the International DLBCL Rituximab-CHOP Consortium Program Study.
Blood.
121:2715-2724.
2013
|
|
| 2013
|
Platelets lacking PIP5KIγ have normal integrin activation but impaired cytoskeletal-membrane integrity and adhesion.
Blood.
121:2743-2752.
2013
|
|
| 2012
|
Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells
2012
|
|
| 2012
|
α-Hemoglobin-stabilizing protein is a sensitive and specific marker of erythroid precursors.
American Journal of Surgical Pathology.
36:1538-1547.
2012
|
|
| 2012
|
Detection of leukemic lymphoblasts in CSF is instrument-dependent.
American Journal of Clinical Pathology.
137:795-799.
2012
|
|
| 2012
|
Self-renewing endodermal progenitor lines generated from human pluripotent stem cells.
Cell Stem Cell.
10:371-384.
2012
|
|
| 2012
|
Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: A comprehensive clinicopathologic and phenotypic study.
American Journal of Surgical Pathology.
36:481-499.
2012
|
|
| 2012
|
G protein βγ-subunit signaling mediates airway hyperresponsiveness and inflammation in allergic asthma.
PLoS One.
7.
2012
|
|
| 2010
|
MicroRNA expression in maturing murine megakaryocytes.
Blood.
116:128-138.
2010
|
|
| 2010
|
Ezrin is highly expressed in early thymocytes, but dispensable for T cell development in mice.
PLoS One.
5.
2010
|
|
| 2010
|
miR-451 protects against erythroid oxidant stress by repressing 14-3-3ζ.
Genes and Development.
24:1620-1633.
2010
|
|
| 2010
|
NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development
2010
|
|
| 2009
|
Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection.
Pediatric Blood and Cancer.
53:1120-1123.
2009
|
|
| 2009
|
ALK expression in rhabdomyosarcomas: Correlation with histologic subtype and fusion status
2009
|
|
| 2009
|
Percentage of γδ T cells in panniculitis by paraffin immunohistochemical analysis.
American Journal of Clinical Pathology.
131:820-826.
2009
|
|
| 2009
|
Loss of pleckstrin defines a novel pathway for PKC-mediated exocytosis.
Blood.
113:3577-3584.
2009
|
|
| 2009
|
Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.
British Journal of Haematology.
145:101-106.
2009
|
|
| 2009
|
Loss of PIP5KIβ demonstrates that PIP5KI isoform-specific PIP 2 synthesis is required for IP3 formation (Proceedings of the National Academy of Sciences of the United States of America (2008) 105, 37, (14064-14069) DOI: 10.1073/pnas.0804139105)
2009
|
|
| 2009
|
A robust xenotransplantation model for acute myeloid leukemia.
Leukemia.
23:2109-2117.
2009
|
|
| 2008
|
Trisomy 21 enhances human fetal erythro-megakaryocytic development.
Blood.
112:4503-4506.
2008
|
|
| 2008
|
Loss of PIP5KIβ demonstrates that PIP5KI isoform-specific PIP 2 synthesis is required for IP3 formation
2008
|
|
| 2008
|
γc-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.
Journal of Immunology.
181:2506-2512.
2008
|
|
| 2008
|
Lethal vascular leak syndrome after denileukin diftitox administration to a patient with cutaneous gamma/delta T-cell lymphoma and occult cirrhosis.
American Journal of Hematology.
83:593-595.
2008
|
|
| 2008
|
Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome.
Blood.
111:3802-3812.
2008
|
|
| 2008
|
Targeting Notch signaling in autoimmune and lymphoproliferative disease.
Blood.
111:705-714.
2008
|
|
| 2007
|
Phospholipase Cβ is critical for T cell chemotaxis.
Journal of Immunology.
179:2223-2227.
2007
|
|
| 2007
|
An erythroid chaperone that facilitates folding of α-globin subunits for hemoglobin synthesis.
Journal of Clinical Investigation.
117:1856-1865.
2007
|
|
| 2007
|
A potential screening tool for IPEX syndrome
2007
|
|
| 2007
|
Mediastinal adenopathy, lung infiltrates, and hemophagocytosis: Unusual manifestation of pediatric anaplastic large cell lymphoma: Report of two cases.
American Journal of Clinical Pathology.
127:458-464.
2007
|
|
| 2007
|
Pediatric primary bone lymphoma-diffuse large B-cell lymphoma: Morphologic and immunohistochemical characteristics of 10 cases.
American Journal of Clinical Pathology.
127:47-54.
2007
|
|
| 2006
|
Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
Blood.
108:1965-1971.
2006
|
|
| 2006
|
The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL.
Blood.
107:1149-1155.
2006
|
|
| 2006
|
Primary non-Hodgkin's lymphoma of bone in children
2006
|
|
| 2005
|
Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways.
Experimental Cell Research.
305:343-354.
2005
|
|
| 2005
|
Early molecular detection of central nervous system relapse in a child with systemic anaplastic large cell lymphoma: Case report and review of the literature.
Pediatric Blood and Cancer.
44:400-406.
2005
|
|
| 2005
|
Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS).
Blood.
105:2443-2448.
2005
|
|
| 2004
|
Identification of cyclin D3 as a direct target of E2A using DamID.
Molecular and Cellular Biology.
24:8790-8802.
2004
|
|
| 2004
|
Neuromedin U: A Myb-regulated autocrine growth factor for human myeloid leukemias.
Blood.
104:1833-1840.
2004
|
|
| 2004
|
Pulmonary hypertension complicating bone marrow transplantation for idiopathic myelofibrosis.
Journal of Pediatric Hematology/Oncology.
26:393-397.
2004
|
|
| 2004
|
Tie2-Cre-Induced Inactivation of a Conditional Mutant Nf1 Allele in Mouse Results in a Myeloproliferative Disorder that Models Juvenile Myelomonocytic Leukemia.
Pediatric Research.
55:581-584.
2004
|
|
| 2004
|
Cell division rates of primary human precursor B cells in culture reflect in vivo rates.
Stem Cells.
22:1111-1120.
2004
|
|
| 2004
|
Immunohistochemical Detection of Aspergillus Species in Pediatric Tissue Samples.
American Journal of Clinical Pathology.
121:18-25.
2004
|
|
| 2004
|
Immunohistochemical detection of Aspergillus species in pediatric tissue samples..
American Journal of Clinical Pathology.
121:18-25.
2004
|
|
| 2002
|
The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl.
Blood.
99:2957-2968.
2002
|
|
| 2001
|
Promotion of cell cycle progression by basic helix-loop-helix E2A.
Molecular and Cellular Biology.
21:6346-6357.
2001
|
|
| 2001
|
Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34+ hematopoietic cells.
Stem Cells.
19:236-246.
2001
|
|
| 1999
|
Hodgkin's disease presenting as a submental mass.
Journal of oral surgery, anesthesia, and hospital dental service.
57:1363-1366.
1999
|
|
| 1998
|
Subcutaneous panniculitis-like T-cell lymphoma. Clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes.
American Journal of Surgical Pathology.
22:881-893.
1998
|
|
| 1998
|
Dispensability of the actin-binding site and spectrin repeats for targeting sarcomeric α-actinin into maturing Z bands in vivo: Implications for in vitro binding studies.
Developmental Biology.
199:291-308.
1998
|
|
| 1998
|
Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant.
Journal of Experimental Medicine.
187:1995-2007.
1998
|
|
| 1997
|
Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway
1997
|
|
| 1997
|
Unanticipated temporal and spatial effects of sarcomeric α-actinin peptides expressed in PtK2 cells.
Cytoskeleton.
38:54-74.
1997
|
|
| 1997
|
Decreased immunoglobulin deposition in tumors and increased immature B cells in p53-null mice.
Molecular Cancer Research.
8:121-131.
1997
|
|
| 1996
|
E47 activates the Ig-heavy chain and TdT loci in non-B cells
1996
|
|
| 1995
|
Increasing intracellular concentrations of thymosin β4 in PtK2 cells: Effects on stress fibers, cytokinesis, and cell spreading.
Cytoskeleton.
31:307-322.
1995
|
|
| 1994
|
Sequential appearance of muscle‐specific proteins in myoblasts as a function of time after cell division: Evidence for a conserved myoblast differentiation program in skeletal muscle.
Cytoskeleton.
29:1-19.
1994
|
|
| 1992
|
A sarcomeric α-actinin truncated at the carboxyl end induces the breakdown of stress fibers in PtK2 cells and the formation of nemaline-like bodies and breakdown of myofibrils in myotubes
1992
|
|
| 1992
|
The vinculin/sarcomeric-α-actinin/α-actin nexus in cultured cardiac myocytes
1992
|
|
| 1992
|
G-actin pool and actin messenger RNA during development of the apical processes of the retinal pigment epithelial cells of the chick.
Developmental Biology.
149:239-246.
1992
|
|
| 1991
|
Phorbol esters selectively and reversibly inhibit a subset of myofibrillar genes responsible for the ongoing differentiation program of chick skeletal myotubes.
Molecular and Cellular Biology.
11:4473-4482.
1991
|
|
| 1990
|
Autonomous Expression of the Differentiation Programs of Cells in the Cardiac and Skeletal Myogenic Lineages.
Annals of the New York Academy of Sciences.
599:158-169.
1990
|
|
| 1990
|
MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes
1990
|
|
| 1983
|
Purification of protein methylase II from human erythrocytes.
Journal of Proteomics.
8:9-14.
1983
|
|
| 1981
|
Microsome-dependent methylation of erythrocyte proteins by dimethylnitrosamine.
Carcinogenesis.
2:179-182.
1981
|
|
| 1981
|
In vitro methylation of human erythrocyte proteins by dimethylnitrosamine
1981
|
|
